Clinical Trials on Hypoparathyroidism Postprocedural in Poland
Total 30 results
-
Region SkaneJagiellonian University; Sahlgrenska University Hospital, Sweden; Haukeland University... and other collaboratorsCompletedHypoparathyroidism PostproceduralNorway, Sweden, Austria, Poland
-
Wroclaw Medical UniversityMinistry of Science and Higher Education, PolandCompletedPrimary HyperparathyroidismPoland
-
Medical University of LodzRecruitingPostoperative Complications | Postoperative Pain | Vitamin D Deficiency | Hypocalcemia | Hypoparathyroidism Postprocedural | Postoperative Nausea | Voice HoarsenessPoland
-
LEO PharmaCompletedSecondary HyperparathyroidismGermany, Poland
-
Amsterdam UMC, location VUmcGroene Hart ZiekenhuisCompletedPneumothorax Iatrogenic Postprocedural | Malposition, Central Venous CatheterNetherlands
-
Amolyt PharmaActive, not recruitingEndocrine System Diseases | Parathyroid Diseases | Chronic HypoparathyroidismUnited States, United Kingdom, Spain, Italy, Netherlands, Denmark, Hungary, Portugal, Germany, France, Canada, Poland
-
AmgenCompletedChronic Kidney Disease, Secondary HyperparathyroidismBelgium, United States, Germany, Poland, United Kingdom, Lithuania
-
AmgenRecruitingSecondary HyperparathyroidismSpain, Belgium, Germany, Czechia, Poland, France, Greece, Hungary, Italy, United Kingdom, Lithuania, Portugal
-
AmgenCompletedHyperparathyroidism, Primary | HypercalcemiaUnited States, Canada, Russian Federation, Hungary, Australia, Portugal, Poland
-
AmgenCompletedSecondary Hyperparathyroidism, Chronic Kidney DiseaseUnited States, Czechia, Germany, France, Hungary, Greece, Belgium, Italy, Poland, Russian Federation, Ukraine
-
ShireCompletedHypoparathyroidismUnited States
-
SanofiActive, not recruitingSecondary Hyperparathyroidism-Chronic Kidney DiseaseUnited States, Chile
-
AmgenTerminatedHyperparathyroidism | Chronic Kidney Disease | Secondary Hyperparathyroidism | Hyperparathyroidism, Secondary | Kidney DiseaseUnited States, Belgium, Hungary, Spain, Australia, Germany, Poland, Mexico, Russian Federation, Slovakia
-
AmgenTerminatedChronic Kidney Disease, Secondary HyperparathyroidismUnited States, Belgium, Italy, Hungary, Czechia, France, Germany, Greece, Spain, Poland, Russian Federation, Ukraine, New Zealand, Slovakia, Lithuania, Portugal
-
ShireCompletedHypoparathyroidismUnited States, Denmark, Canada, Hungary, United Kingdom, Belgium, France, Italy
-
TakedaTakeda Development Center Americas, Inc.Active, not recruitingHypoparathyroidismUnited States, Spain, Denmark, Germany, Austria, Canada, Greece, Sweden, Italy, Norway, United Kingdom
-
AbbVie (prior sponsor, Abbott)North America Pediatric Renal Trials and Collaborative Studies (NAPRTCS)TerminatedEnd-Stage Renal Disease | Secondary HyperparathyroidismUnited States
-
AmgenCompletedSecondary HyperparathyroidismUnited States, Italy, Belgium, Switzerland, Hungary, Spain, Turkey, Poland, Portugal, United Kingdom, Czech Republic, Macedonia, The Former Yugoslav Republic of
-
ShireCompletedHypoparathyroidismUnited States, Spain, United Kingdom, Denmark, France, Norway, Belgium, Canada, Portugal, Sweden, Italy, Netherlands, Germany
-
AmgenCompletedChronic Kidney Disease | Secondary HyperparathyroidismUnited States, Italy, Belgium, Denmark, Switzerland, Canada, Turkey, Spain, Austria, Germany, Hungary, Greece, France, Poland, Russian Federation, Czechia, Latvia, Lithuania, New Zealand, Portugal, Sweden, Estonia
-
AmgenTerminatedChronic Kidney Disease | Hyperparathyroidism, SecondaryUnited States, Belgium, Italy, Hungary, Czechia, France, Germany, Poland, Netherlands, Russian Federation, New Zealand, Mexico, Slovakia
-
Pathalys PharmaLaunch TherapeuticsRecruitingSecondary Hyperparathyroidism | End Stage Kidney DiseaseUnited States, Bulgaria, Portugal, Spain, Serbia, Poland
-
Pathalys PharmaLaunch TherapeuticsRecruitingSecondary Hyperparathyroidism | End-stage Kidney Disease (ESKD)United States, Bulgaria, Spain, Portugal, Poland, Serbia
-
AmgenCompletedHyperparathyroidism, SecondaryUnited States, Belgium, Italy, United Kingdom, Canada, Germany, Spain, Austria, Czechia, Hungary, France, Israel, Poland, Australia, Russian Federation
-
AmgenCompletedHyperparathyroidism, SecondaryUnited States, Belgium, Italy, Switzerland, Canada, Turkey, Spain, Australia, Austria, Israel, Czechia, Hungary, Poland, France, Russian Federation, Germany, Denmark, Greece, Latvia, Lithuania, Netherlands, New Zealand, Portugal, Sweden
-
AmgenCompletedHyperparathyroidism, SecondaryUnited States, Belgium, Canada, France, Australia, Israel, Czechia, Hungary, Netherlands, Spain, Poland, Russian Federation, Italy, Sweden, Germany
-
AmgenCompletedHyperparathyroidism, SecondaryUnited States, Belgium, Italy, United Kingdom, Canada, Germany, Spain, Australia, Austria, Israel, Czechia, Hungary, Netherlands, Poland, France, Russian Federation, Sweden
-
AmgenCompletedHyperparathyroidism | End Stage Renal Disease | Chronic Kidney Disease | Kidney Transplantation | Chronic Renal Failure | Hypophosphatemia | Kidney Disease | Chronic Allograft Nephropathy | Disordered Mineral Metabolism | Post Renal TransplantationUnited States, Canada, France, Italy, Belgium, Switzerland, Spain, Australia, Germany, Austria, Poland
-
dr. Laura C. G. de Graaff-HerderRecruitingDisorders of Sex Development | Congenital Adrenal Hyperplasia | Tuberous Sclerosis | Kallmann Syndrome | Prader-Willi Syndrome | Neurofibromatosis | Rett Syndrome | 22q11 Deletion Syndrome | Turner Syndrome | Noonan Syndrome | Allan-Herndon-Dudley Syndrome | Saethre-Chotzen Syndrome | Congenital Hypopituitarism | Cornelia... and other conditionsNetherlands